Processa Pharmaceuticals, Inc.
PCSA
$1.99
-$0.17-7.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.27M | -3.38M | -3.36M | -3.44M | -3.93M |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.02M | 155.80K | -171.60K | 327.40K | 226.70K |
| Change in Net Operating Assets | 249.90K | -369.60K | 629.70K | -375.50K | 1.44M |
| Cash from Operations | -2.00M | -3.59M | -2.90M | -3.48M | -2.27M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 186.00K | -500.00K | -850.00K | -- | -- |
| Cash from Investing | 186.00K | -500.00K | -850.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -3.80K | -1.30K |
| Issuance of Common Stock | 315.20K | 245.10K | 2.98M | 2.86M | 6.32M |
| Repurchase of Common Stock | 0.00 | -300.00 | 0.00 | 0.00 | -9.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 315.20K | 244.80K | 2.98M | 2.86M | 6.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.49M | -3.85M | -771.50K | -628.20K | 4.04M |